Medicare's New Drug Price Mandate: Healthcare & Innovation Implications
A Regulatory Transparency Project Webinar
On January 17, the Biden-Harris Administration added 15 new drugs, including Ozempic, to the list of...
Regulatory Transparency Project
The Regulatory Transparency Project was a nonprofit, nonpartisan effort dedicated to fostering discussion and a better understanding of regulatory policies.
Commentary
Medicare's New Drug Price Mandate: Healthcare & Innovation Implications
A Regulatory Transparency Project Webinar
On January 17, the Biden-Harris Administration added 15 new drugs, including Ozempic, to the list of...
Reducing Regulatory Barriers: The Future of Market Competition
On April 9th, President Trump signed E.O. 14267, Reducing Anti-Competitive Regulatory Barriers, which “commences the process...
Can the President Shut Down the Department of Education?
A Regulatory Transparency Project Webinar
On March 20, President Trump signed E.O. 14242, Improving Education Outcomes by Empowering Parents, States, and Communities,...
Explainer Episode 90 - Disparate Impact and the Future of Equal Opportunity
RTP's Fourth Branch Podcast
On April 23, President Trump signed E.O. 14281, Restoring Equality of Opportunity and Meritocracy, declaring...
